Cannabidiol patent applications http://tgs.freshpatents.com/Cannabidiol-bx1.php The latest patent applications on FreshPatents.com related to Cannabidiol en-us Wed, 30 Jul 2014 07:36:18 -0700 1000 FreshPatents.com: Recent Cannabidiol patent applications 141 31 http://tgs.freshpatents.com/Cannabidiol-bx1.php http://www.freshpatents.com/images/freshpatentsnav_rss.gif Use of cannabidiol in the treatment of hepatitis http://www.freshpatents.com/-dt20121129ptan20120302646.php Fri, 30 Nov 2012 00:00:00 -0800 Cannabinoids are known to interact with CB1 and CB2 receptors expressed in the nervous and immune systems mediating a wide range of effects, including anti-inflammatory properties. However, cannabinoids that bind CB1 are also psychoactive thereby limiting their clinical use. Cannabidiol (CBD) is the most abundant nonpsychotropic plant cannabinoid but has not... Pharmaceutical composition comprising cannabinoids http://www.freshpatents.com/-dt20121122ptan20120295968.php Fri, 23 Nov 2012 00:00:00 -0800 The present invention relates to a pharmaceutical composition comprising Δ9 Tetrahydrocannabinol (THC), Cannabidiol (CBD), and at least one small molecule selected from Citric Acid, Ascorbic Acid, Citrus Essential Oil(s), Lecithin, one or more sugar(s), Resvertrol, and combinations thereof, wherein the composition exhibits an increased but negated psychoactivity with concurrent enhancement in... Cannabinoids for use in the treatment of neuropathic pain http://www.freshpatents.com/-dt20120927ptan20120245224.php Fri, 28 Sep 2012 00:00:00 -0700 The present invention relates to the use of cannabidiol (CBD) type compounds or derivative thereof and tetrahydrocannabinol (THC) type compounds or derivative thereof in the manufacture of a medicament for the treatment of neuropathic pain. Preferably, the ratio of the CBD type compounds or derivative thereof and THC type compounds or... Transdermal delivery of cannabinoids http://www.freshpatents.com/-dt20120209ptan20120034293.php Fri, 10 Feb 2012 00:00:00 -0800 The present invention overcomes the problems associated with existing drug delivery systems by delivering cannabinoids transdermally. Preferably, the cannabinoids are delivered via an occlusive body (i.e., a patch) to alleviate harmful side effects and avoid gastrointestinal (first-pass) metabolism of the drug by the patient. A first aspect of the invention provides... Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy http://www.freshpatents.com/-dt20120105ptan20120004251.php Fri, 06 Jan 2012 00:00:00 -0800 This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one... Abnormal cannabidiols as agents for lowering intraocular pressure http://www.freshpatents.com/-dt20111103ptan20110269715.php Fri, 04 Nov 2011 00:00:00 -0700 The present invention further comprises pharmaceutical compositions, e.g. ophthalmic compositions, including said compound. wherein Y, Q, Z, R, R1 and R2 are as defined in the specification. The present invention provides a method of treating glaucoma or ocular hypertension which comprises applying to the eye of a person in need thereof an amount... Process for production of delta-9-tetrahydrocannabinol http://www.freshpatents.com/-dt20111027ptan20110263878.php Fri, 28 Oct 2011 00:00:00 -0700 where R8, R9, and R10 are the same or different and independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or halo, with R1, R2, and R3 defined herein. The present invention relates to a process for preparation of a delta-9-tetrahydrocannabinol... Treatment of hepatic encephalopathy and liver cirrhosis http://www.freshpatents.com/-dt20111013ptan20110251290.php Fri, 14 Oct 2011 00:00:00 -0700 The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.... Pharmaceutical compositions for the treatment of pain http://www.freshpatents.com/-dt20110922ptan20110230549.php Fri, 23 Sep 2011 00:00:00 -0700 The present invention relates to treatment of cancer related pain and constipation. Preferably the subject in need is administered a combination of the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). More preferably the cannabinoids are in a predefined ratio by weight of approximately 1:1 of CBD to THC.... Anti-tumoural effects of cannabinoid combinations http://www.freshpatents.com/-dt20110519ptan20110117216.php Fri, 20 May 2011 00:00:00 -0700 The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme... Use of cannabidiol prodrugs in topical and transdermal administration with microneedles http://www.freshpatents.com/-dt20110303ptan20110052694.php Fri, 04 Mar 2011 00:00:00 -0800 Described herein are microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery of the active agent to a mammal. Also described herein are methods of using a microneedle transdermal or topical drug delivery... Use of cannabinoids in combination with an anti-psychotic medicament http://www.freshpatents.com/-dt20110217ptan20110038958.php Fri, 18 Feb 2011 00:00:00 -0800 The present invention relates to the use of one or more cannabinoids in combination with one or more anti-psychotic medicaments for use in the prevention or treatment of psychosis and psychotic disorders. Preferably the one or more cannabinoids are taken from the group: cannabidiol (CBD); cannabidiolic acid (CBDA); tetrahydrocannbidivarin (THCV); tetrahydrocannbidivarinin... Medicinal acidic cannabinoids http://www.freshpatents.com/-dt20110127ptan20110021617.php Fri, 28 Jan 2011 00:00:00 -0800 The invention relates to an acidic cannabinoid for medical use and to a cannabis extract comprising an acidic cannabinoid. The extract may comprise one or more compounds selected from the group consisting of cannabidiolic acid (CBD-A), cannabidiol (CBD), cannabigerolic acid (CBGA), cannabigerol (CBG), cannabinolic acid (CBN-A) and cannabinol. The invention further...